Interferon-α-carboplatin combination therapy for metastatic melanoma: Phase II study-Reference-Cited by-同舟云学术

Interferon-α-carboplatin combination therapy for metastatic melanoma: Phase II study

Published:1994-01 Issue:14 Volume:30 Page:2182-2183
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Kokoschka E.M.,Klocker J.,Loicht U.,Rehberger A.,Macheiner W.,Micksche M.

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference9 articles.

1. Malignant melanoma. Educational book;Parkinson;Am Soc Clin Oncol,1993

2. Role of interferons in the therapy of melanoma;Kirkwood;J Invest Dermatol,1990

3. Antineoplastic activity of the combination of interferon and cytotoxic agents against experimental and human malignancies. A review;Wadler;Cancer Res,1990

4. Phase II trial of cisplatin and α-interferon in advanced malignant melanoma;Margolin;J Clin Oncol,1992

5. Phase II study of continuous subcutaneous alpha 2b interferon (IFN) combined withi cisplatin (CDDP) in advanced malignant melanoma (MM);Richner,1990

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Survie prolongée et régression tumorale spontanée au cours d’un mélanome de stade IV : rôles possibles de la surrénalectomie et de la libération massive d’antigènes tumoraux;Annales de Dermatologie et de Vénéréologie;2010-06

2. Long-term survivors in stage IV melanoma: a regional population-based study in France;European Journal of Dermatology;2009-01

3. Interferon-α Therapy in Dermatology;Strategies for Immunointerventions in Dermatology;1997

4. Complete remission seven years after treatment for metastatic malignant melanoma;Cancer;1996-03-01